HEOR
Evidence that drives access and impact.
Developed in close partnership with life sciences companies, our evidence generation capabilities support confident decision-making across value, access, and adoption—ensuring health care innovations reach the patients who need them most.
Our Solutions
HEOR Strategy
Develop robust HEOR strategies that generate credible, stakeholder-aligned evidence to meet the rigorous expectations of payers, HTA organizations, policymakers, and health care decision-makers.
• Market and disease state insights
• Evidence generation plans
• Stakeholder validation
Evidence Synthesis
Combine real-world data with published findings using advanced synthesis techniques to close evidence gaps and clearly communicate the value of your health care innovation.
• Targeted and systematic literature reviews
• Network meta-analysis
• Population-adjusted indirect comparisons
• Validation of surrogate endpoints
• Living evidence synthesis
Health Economic Modeling
Develop credible, health economic, and simulation models to quantify the value and population health impact of your innovation for HTA submissions, payer engagement, and other stakeholder needs.
• Cost-effectiveness and budget impact models
• Generalized cost-effectiveness analysis to include novel value elements
• Health equity impact evaluations and distributional cost-effectiveness analysis
• Treatment sequence comparisons
Evidence Generation
Conduct empirical studies using existing data sources and primary data collection to evaluate disease burden, treatment patterns, clinical outcomes, and stakeholder preferences through EMRs, claims, registries, surveys, and direct engagement.
• Observational RWE studies
• External controls
• Patient, payer, provider, and caregiver preference studies
• Expert elicitation and Delphi panels
• Qualitative and mixed-methods research
HTA Submission & Support
Navigate HTA requirements with precision to ensure that evidence is strategically communicated, maximizing the likelihood of favorable reimbursement decisions.
• HTA dossiers
• ICER defense
• Strategic support
.png)
International Access Strategy Services
Navigate the complexity of global pharmaceutical markets with strategies tailored to diverse health care systems, patient populations, and evidence expectations. We blend technical know-how with strategic expertise to help biopharma companies overcome access barriers, manage cross-market pricing risks, and unlock commercial success worldwide.